Douglas Lane & Associates, LLC Elanco Animal Health Inc Transaction History

Douglas Lane & Associates, LLC

$6.89 Billion
Q2 2024

A detailed history of Douglas Lane & Associates, LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 3,730,435 shares of ELAN stock, worth $54.1 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

3,730,435

Previous 3,909,460 4.58%

Holding current value

$54.1 Million

Previous $63.6 Million 15.42%

% of portfolio

0.78%

Previous 0.94%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 08, 2024	SELL	$12.93 - $18.45 $2.31 Million - $3.3 Million	-179,025 Reduced 4.58%	3,730,435 $53.8 Million
Q1 2024 Apr 11, 2024	SELL	$14.37 - $16.46 $255,354 - $292,494	-17,770 Reduced 0.45%	3,909,460 $63.6 Million
Q4 2023 Jan 17, 2024	SELL	$8.6 - $14.94 $349,082 - $606,429	-40,591 Reduced 1.02%	3,927,230 $58.5 Million
Q3 2023 Oct 16, 2023	BUY	$9.81 - $12.62 $8.72 Million - $11.2 Million	889,295 Added 28.89%	3,967,821 $44.6 Million
Q2 2023 Jul 19, 2023	BUY	$8.08 - $10.37 $4.96 Million - $6.36 Million	613,580 Added 24.89%	3,078,526 $31 Million
Q1 2023 Apr 17, 2023	BUY	$8.79 - $14.58 $2.52 Million - $4.17 Million	286,222 Added 13.14%	2,464,946 $23.2 Million
Q4 2022 Feb 14, 2023	SELL	$11.49 - $13.65 $103,122 - $122,508	-8,975 Reduced 0.41%	2,178,724 $26.6 Million
Q4 2022 Jan 17, 2023	SELL	$11.49 - $13.65 $2.7 Million - $3.2 Million	-234,635 Reduced 9.69%	2,187,699 $26.7 Million
Q3 2022 Oct 14, 2022	SELL	$12.41 - $32.42 $1.63 Million - $4.25 Million	-131,151 Reduced 5.14%	2,422,334 $30.1 Million
Q2 2022 Jul 18, 2022	BUY	$19.63 - $26.62 $1.14 Million - $1.54 Million	57,964 Added 2.32%	2,553,485 $50.1 Million
Q1 2022 Apr 25, 2022	BUY	$24.65 - $29.0 $3.34 Million - $3.93 Million	135,410 Added 5.74%	2,495,521 $65.1 Million
Q4 2021 Jan 25, 2022	BUY	$27.74 - $34.09 $3.28 Million - $4.03 Million	118,101 Added 5.27%	2,360,111 $67 Million
Q3 2021 Oct 21, 2021	BUY	$29.2 - $36.72 $1.79 Million - $2.25 Million	61,322 Added 2.81%	2,242,010 $71.5 Million
Q2 2021 Jul 19, 2021	BUY	$28.76 - $35.98 $13.1 Million - $16.4 Million	454,605 Added 26.34%	2,180,688 $75.6 Million
Q1 2021 Apr 19, 2021	BUY	$27.85 - $34.49 $11.7 Million - $14.5 Million	421,004 Added 32.26%	1,726,083 $50.8 Million
Q4 2020 Jan 14, 2021	BUY	$27.53 - $33.79 $3.15 Million - $3.87 Million	114,455 Added 9.61%	1,305,079 $40 Million
Q3 2020 Oct 19, 2020	BUY	$21.1 - $29.13 $5.65 Million - $7.79 Million	267,580 Added 28.99%	1,190,624 $33.3 Million
Q2 2020 Jul 28, 2020	BUY	$18.94 - $24.93 $5.93 Million - $7.81 Million	313,332 Added 51.39%	923,044 $19.8 Million
Q1 2020 Apr 20, 2020	BUY	$16.68 - $32.25 $8.16 Million - $15.8 Million	489,240 Added 406.1%	609,712 $13.7 Million
Q4 2019 Jan 27, 2020	BUY	$25.29 - $29.45 $3.05 Million - $3.55 Million	120,472 New	120,472 $3.55 Million

Others Institutions Holding ELAN

# of Institutions

447

Shares Held

478M

Call Options Held

3.1M

Put Options Held

1.26M

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.87B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Account

Douglas Lane & Associates, LLC Elanco Animal Health Inc Transaction History